Browsing: Other

A randomized trial of 219 women receiving chemotherapy for breast cancer with concurrent insomnia demonstrated a significant improvement with cognitive…

This debate asks the hard question of whether a physical exam adds more than show in the evaluation of an…

In GETUG AFU 18, did dose escalated prostate radiation improve clinical progression free survival compared with lower dose RT in…

This editorial calls for busy rad onc practices to shift from a mindset of “design the treatment plan to eliminate…

This editorial argues, as artificial intelligence increasingly automates physicians’ cognitive and documentation tasks, its efficiency gains must be used to…

When the PORTOS radiation response signature was run on breast cancer tumors that did or did not receive adjuvant breast…

A population-based cross-sectional analysis of 12.7 million US deaths found that pilots and flight attendants had the highest risk-adjusted proportions…

Does pluvicto improve radiographic PFS in patients with metastatic, castration sensitive prostate cancer receiving ADT and an androgen receptor blocker?Is…

In the NEOTRAC study, did neoadjuvant RT following neoadjuvant systemic therapy for HER2 positive breast cancer improve response rates?What was…

The randomized phase 2 SOLARIS trial failed to demonstrate improved disease control with high-dose (4000 IU daily) versus standard-dose (400…